Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 316

    1.

    The effectiveness of beta-blockers after myocardial infarction in patients with type 2 diabetes.

    McDonald CG, Majumdar SR, Mahon JL, Johnson JA.

    Diabetes Care. 2005 Sep;28(9):2113-7.PMID: 16123475 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients. Results from the National Cooperative Cardiovascular Project.

    Chen J, Marciniak TA, Radford MJ, Wang Y, Krumholz HM.

    J Am Coll Cardiol. 1999 Nov 1;34(5):1388-94.PMID: 10551683 [PubMed - indexed for MEDLINE]Related articles

    3.

    National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.

    Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA.

    JAMA. 1998 Aug 19;280(7):623-9. Erratum in: JAMA 1999 Jan 6;281(1):37. PMID: 9718054 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction.

    Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L.

    JAMA. 1997 Jan 8;277(2):115-21.PMID: 8990335 [PubMed - indexed for MEDLINE]Related articles

    5.

    Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group.

    Jonas M, Reicher-Reiss H, Boyko V, Shotan A, Mandelzweig L, Goldbourt U, Behar S.

    Am J Cardiol. 1996 Jun 15;77(15):1273-7.PMID: 8677865 [PubMed - indexed for MEDLINE]Related articles

    6.

    Type of preadmission glucose-lowering treatment and prognosis among patients hospitalised with myocardial infarction: a nationwide follow-up study.

    Horsdal HT, Johnsen SP, Søndergaard F, Rungby J.

    Diabetologia. 2008 Apr;51(4):567-74. Epub 2008 Feb 19.PMID: 18283428 [PubMed - indexed for MEDLINE]Related articles

    7.

    Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.

    Lanfear DE, Jones PG, Marsh S, Cresci S, McLeod HL, Spertus JA.

    JAMA. 2005 Sep 28;294(12):1526-33.PMID: 16189366 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients.

    Waldecker B, Waas W, Haberbosch W, Voss R, Steen-Müller MK, Hiddessen A, Bretzel R, Tillmanns H.

    Diabetes Care. 1999 Nov;22(11):1832-8.PMID: 10546016 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Beta-blocker dosages and mortality after myocardial infarction: data from a large health maintenance organization.

    Barron HV, Viskin S, Lundstrom RJ, Swain BE, Truman AF, Wong CC, Selby JV.

    Arch Intern Med. 1998 Mar 9;158(5):449-53.PMID: 9508222 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Health and economic benefits of increased beta-blocker use following myocardial infarction.

    Phillips KA, Shlipak MG, Coxson P, Heidenreich PA, Hunink MG, Goldman PA, Williams LW, Weinstein MC, Goldman L.

    JAMA. 2000 Dec 6;284(21):2748-54.PMID: 11105180 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Impact of pharmacological treatment on mortality after myocardial infarction in diabetic patients.

    Zuanetti G, Latini R.

    J Diabetes Complications. 1997 Mar-Apr;11(2):131-6. Review.PMID: 9101399 [PubMed - indexed for MEDLINE]Related articles

    13.

    Reduced mortality associated with the use of ACE inhibitors in patients with type 2 diabetes.

    Eurich DT, Majumdar SR, Tsuyuki RT, Johnson JA.

    Diabetes Care. 2004 Jun;27(6):1330-4.PMID: 15161784 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.

    Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC.

    J Am Coll Cardiol. 2008 Apr 1;51(13):1247-54.PMID: 18371553 [PubMed - indexed for MEDLINE]Related articles

    15.

    Depression is a risk factor for mortality after myocardial infarction: fact or artifact?

    Dickens C, McGowan L, Percival C, Tomenson B, Cotter L, Heagerty A, Creed F.

    J Am Coll Cardiol. 2007 May 8;49(18):1834-40. Epub 2007 Apr 20.PMID: 17481442 [PubMed - indexed for MEDLINE]Related articles

    16.

    Utility of beta-blockade treatment for older postinfarction patients.

    Park KC, Forman DE, Wei JY.

    J Am Geriatr Soc. 1995 Jul;43(7):751-5.PMID: 7602025 [PubMed - indexed for MEDLINE]Related articles

    17.

    Traditional versus marginal structural models to estimate the effectiveness of beta-blocker use on mortality after myocardial infarction.

    Delaney JA, Daskalopoulou SS, Suissa S.

    Pharmacoepidemiol Drug Saf. 2009 Jan;18(1):1-6.PMID: 18949804 [PubMed - indexed for MEDLINE]Related articles

    18.

    Underuse of beta-blockers following myocardial infarction: a tale of two cities.

    Nicholls SJ, McElduff P, Dobson AJ, Jamrozik KD, Hobbs MS, Leitch JW.

    Intern Med J. 2001 Sep-Oct;31(7):391-6.PMID: 11584900 [PubMed - indexed for MEDLINE]Related articles

    19.

    A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery.

    Kertai MD, Boersma E, Westerhout CM, Klein J, Van Urk H, Bax JJ, Roelandt JR, Poldermans D.

    Eur J Vasc Endovasc Surg. 2004 Oct;28(4):343-52.PMID: 15350554 [PubMed - indexed for MEDLINE]Related articles

    20.

    Outcomes of inappropriate prescribing of beta-blockers after an acute myocardial infarction in a Medicaid population.

    Fernandes AW, Madhavan SS, Amonkar MM, Bell D, Islam SS, Scott VG.

    Ann Pharmacother. 2005 Sep;39(9):1416-22. Epub 2005 Jun 21.PMID: 15972326 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data